Buying cures versus renting health: Financing health care with consumer loans-Reference-Cited by-同舟云学术

Buying cures versus renting health: Financing health care with consumer loans

Published:2016-02-24 Issue:327 Volume:8 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Montazerhodjat Vahid¹²,Weinstock David M.³⁴,Lo Andrew W.¹²⁵⁶

Affiliation:

1. MIT Laboratory for Financial Engineering, Sloan School of Management, Cambridge, MA, USA.

2. MIT Department of Electrical Engineering and Computer Science, Cambridge, MA, USA.

3. Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

4. Broad Institute of Harvard and MIT, Cambridge, MA, USA.

5. MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.

6. AlphaSimplex Group LLC, Cambridge, MA, USA.

Abstract

Health care loans—the equivalent of mortgages for large health care expenses—are a practical way to increase patient access to costly transformative therapies.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference31 articles.

1. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

2. Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

3. Global distribution and prevalence of hepatitis C virus genotypes

4. The special case of gene therapy pricing

5. 5.T. Philipson A. von Eschenbach Medical breakthroughs and credit markets. Forbes (9 July 2014). www.forbes.com/sites/tomasphilipson/2014/07/09/medical-breakthroughs-and-credit-markets.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for ultrarare diseases: a geneticist’s perspective;Journal of Biomedical Science;2024-08-13

2. Approval and therapeutic value of gene therapies in the US and Europe;Gene Therapy;2023-11

3. The estimated annual financial impact of gene therapy in the United States;Gene Therapy;2023-11

4. Confronting High Costs And Clinical Uncertainty: Innovative Payment Models For Gene Therapies;Health Affairs;2023-11-01

5. Financial intermediation and the funding of biomedical innovation: A review;Journal of Financial Intermediation;2023-04